Cullen/Frost Bankers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.14M Buy
117,889
+1,060
+0.9% +$73.2K 0.1% 173
2025
Q1
$8.11M Buy
116,829
+1,387
+1% +$96.3K 0.11% 166
2024
Q4
$9.93M Buy
115,442
+57
+0% +$4.9K 0.14% 148
2024
Q3
$13.7M Buy
115,385
+380
+0.3% +$45.2K 0.19% 126
2024
Q2
$16.4M Buy
115,005
+505
+0.4% +$72.1K 0.24% 102
2024
Q1
$14.7M Sell
114,500
-14
-0% -$1.8K 0.22% 116
2023
Q4
$11.8M Buy
114,514
+38
+0% +$3.93K 0.19% 131
2023
Q3
$10.4M Sell
114,476
-3,418
-3% -$311K 0.18% 129
2023
Q2
$9.54M Buy
117,894
+32,574
+38% +$2.64M 0.16% 144
2023
Q1
$6.79M Buy
85,320
+298
+0.4% +$23.7K 0.12% 168
2022
Q4
$5.75M Buy
85,022
+2,100
+3% +$142K 0.11% 177
2022
Q3
$4.13M Sell
82,922
-70
-0.1% -$3.49K 0.09% 177
2022
Q2
$4.62M Sell
82,992
-376
-0.5% -$20.9K 0.1% 175
2022
Q1
$4.63M Sell
83,368
-388
-0.5% -$21.5K 0.09% 188
2021
Q4
$4.69M Sell
83,756
-3,120
-4% -$175K 0.09% 195
2021
Q3
$4.17M Sell
86,876
-3,742
-4% -$180K 0.08% 199
2021
Q2
$3.8M Sell
90,618
-41,044
-31% -$1.72M 0.08% 202
2021
Q1
$4.44M Buy
131,662
+4,882
+4% +$165K 0.1% 187
2020
Q4
$4.43M Buy
126,780
+2,932
+2% +$102K 0.1% 175
2020
Q3
$4.3M Buy
123,848
+6,714
+6% +$233K 0.11% 165
2020
Q2
$3.84M Buy
117,134
+81,706
+231% +$2.68M 0.1% 176
2020
Q1
$1.07M Buy
+35,428
New +$1.07M 0.04% 248
2019
Q4
Sell
-132
Closed -$3K 1084
2019
Q3
$3K Sell
132
-18
-12% -$409 ﹤0.01% 952
2019
Q2
$4K Buy
150
+12
+9% +$320 ﹤0.01% 935
2019
Q1
$4K Buy
+138
New +$4K ﹤0.01% 822